Mission
To promote, coordinate and support activities in the areas of clinical and translational research (CI&T) and biomedical innovation, contributing to the optimization of Portugal’s clinical, scientific and technological potential.
Vision
AICIB aims to be a national and European reference as an entity capable of creating the essential conditions to stimulate clinical research and biomedical innovation in Portugal.
Objectives
To Carry out activities of national interest in financing and promoting IC&T and biomedical innovation through support for its development and internationalization.
Streamline R&D activities and cooperation between health care units, other health institutions (DGS, IPS, ACSS, SPMS, INSA, among others), scientific and academic institutions, and the various stakeholders involved in the process. The aim is to synergistically stimulate their potential, increasing value for society, patients, the health system and the training of health professionals in IC&T.
To Promote a scientific culture and the creation of economic value in the area of health, ensuring its sustainability and the adoption of best practices established nationally and internationally.
Organization Chart
General Assembly
Presidente
Paula Alves
Vice-presidente
José Paulo Esperança
Secretário
António Faria Vaz
Fiscal Council
Presidente
Emília Alves
Vice-presidente
Miguel Andrade
Revisor Oficial de Contas
João Careca
Direction
Presidente
Catarina Resende Oliveira
Vice-presidente
Teresa Machado Luciano
Vogal Executiva
Anabela Isidro
Vogal
Heitor Costa
Vogal
João Cerqueira
Advisory Board
AICIB’s Constitution and By-Laws
Resolution of the Council of Ministers – Authorization for the constitution of AICIB – Agency for Clinical Research and Biomedical Innovation and the Statutes of AICIB are available for consultation in the Republic’s Diary.
Beatriz Silva Lima
Especialista em Farmacologia
Professora de farmacologia e farmacotoxicologia na Faculdade de Farmácia da Universidade de Lisboa; perita europeia no Innovative Medicines Initiative
Cristina Sampaio
Investigadora do IMM; Chief Clinical Officer da CHDI Foundation (Center for Huntington Disease Investigation) em Nova Iorque, EUA
Joana Maia
Responsável pela equipa de Study Coordinators do IPO do Porto
Joaquim Murta
Diretor de Serviço de Oftalmologia, Centro Hospitalar
e Universitário de Coimbra
José Dinis
Luís Costa
Diretor do Departamento de Oncologia do Hospital de Santa Maria – Centro Hospitalar Lisboa Norte
Nuno Marques
Professor Auxiliar Convidado, Dep. Ciências Biomédicas e Medicina, Universidade do Algarve; Presidente, Algarve Biomedical Center
Patrício Soares da Silva
Professor Catedrático de “Terapêutica e Farmacologia Clínica”, Universidade do Porto